Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
Clinical Pharmacology and Therapeutics|July 8, 2024
Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White PaperAarti Sawant-Basak, Shweta Urva, Jatinder Kaur Mukker, et al.
International Journal of Cancer|June 24, 2009
Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinomaAjay Matta, Satyendra Chandra Tripathi, Leroi V DeSouza, et al.
Clinical Pharmacology and Therapeutics|February 13, 2026
Advancing Pharmacoequity Globally: Reflections from the ASCPT Development, Regulatory, and Outcomes NetworkPriya Jayachandran, Mayur K Ladumor, Georgios Vlasakakis, et al.
Plos One|December 15, 2010
Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancersRanju Ralhan, Helen C-H He, Anthony K-C So, et al.
Vaccines|March 30, 2023
Immune Control of Avian Influenza Virus Infection and Its Vaccine DevelopmentPiyush Dey, Akanksha Ahuja, Jaishal Panwar, et al.
Plos One|May 17, 2011
Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancerSatyendra Chandra Tripathi, Ajay Matta, Jatinder Kaur, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 18, 2011
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinomaSatyendra Chandra Tripathi, Jatinder Kaur, Ajay Matta, et al.
International Journal of Cancer|February 18, 2010
KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinsesSemra Demokan, Xiaofei Chang, Alice Chuang, et al.
Journal of Translational Medicine|January 17, 2015
Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patientsManish Kumar, Gunjan Srivastava, Jatinder Kaur, et al.
Pageof 20